This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Problems related to care-provider dependency
Z21_PROBL_RELATED_CARE__DEPENDENCY
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
348 |
4. Check minimum number of eventsNone |
348 |
5. Include endpointsNone |
348 |
6. Filter based on genotype QC (FinnGen only) |
301 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z7
Similar endpoints
↥List of similar endpoints to
Problems related to care-provider dependency
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services in other circumstances, wide
- Factors influencing health status and contact with health services
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 301 | 127 | 174 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 76.05 | 75.79 | 76.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 307
- Matched controls
- 3070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
+∞
137.0
121
*
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
+∞
74.0
68
*
Z74.1
ICD-10 Finland
Need for assistance with personal care
+∞
56.0
52
*
Z74.8
ICD-10 Finland
Other problems related to care-provider dependency
+∞
46.0
43
*
Z75.5
ICD-10 Finland
Holiday relief care
+∞
43.8
41
*
N03AG01
ATC
valproic acid; systemic, rectal
9.5
38.3
49
60
N05AH03
ATC
olanzapine; systemic
8.5
30.5
42
56
A29
ICPC
General symptom/complaint other
4.5
29.0
90
260
N05AX08
ATC
risperidone; systemic
4.7
28.1
80
216
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.7
25.4
70
183
Z74.9
ICD-10 Finland
Problem related to care-provider dependency, unspecified
+∞
24.3
23
*
A28
ICPC
Limited function/disability NOS
3.5
24.3
123
492
SPAT1229
SPAT
Assessment of need for aid
4.9
23.5
58
138
R51
NOMESCO Finland
Aids services
+∞
23.2
22
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
22.8
95
333
A06AD11
ATC
lactulose; oral
3.3
21.0
107
424
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.3
20.9
63
175
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
20.6
38
69
N05AH04
ATC
quetiapine; oral
3.7
20.0
79
265
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.0
19.5
25
30
F03
ICD-10 Finland
Unspecified dementia
4.2
18.7
56
154
N02AA05
ATC
oxycodone; systemic
3.1
18.4
104
434
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
17.6
91
359
SPAT1262
SPAT
Handing over of treatment supplies
3.3
17.4
82
306
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
17.3
149
775
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.7
17.2
34
66
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
16.8
86
337
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.0
16.7
53
152
WX704
NOMESCO Finland
Intubation
4.9
15.7
37
84
N05BA04
ATC
oxazepam; oral
2.8
15.6
111
518
N05AA02
ATC
levomepromazine; systemic
6.2
15.2
27
47
N03AE01
ATC
clonazepam; systemic
5.3
14.4
30
61
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.3
14.3
62
218
CA1ME
NOMESCO Finland
Ultrasound oculometry
25.2
14.0
19
8
WZC00, ,
SPAT
3.5
13.9
55
182
N05AD01
ATC
haloperidol; systemic
5.5
13.9
28
55
N05BA06
ATC
lorazepam; systemic, sublingual
4.5
13.3
34
82
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.8
13.3
25
46
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.8
13.2
31
70
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.4
13.0
35
88
N30.0
ICD-10 Finland
Acute cystitis
3.0
12.6
65
252
K90
ICPC
Stroke/cerebrovascular accident
5.7
12.5
24
45
R53
ICD-10 Finland
Malaise and fatigue
2.5
12.3
106
534
N06AB04
ATC
citalopram; systemic
2.7
12.2
86
393
J01MA02
ATC
ciprofloxacin; systemic
2.4
12.2
152
902
N03AF01
ATC
carbamazepine; oral, rectal
4.2
12.2
34
88
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
12.2
38
107
SPAT1255
SPAT
Intravenous administration of medicine
3.9
12.0
37
103
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.2
11.9
25
51
SPAT1249
SPAT
Treatment-related counselling outside office
2.4
11.8
123
674
P29
ICPC
Psychological sympt/compl other
5.0
11.6
26
56
N05BA01
ATC
diazepam; systemic, rectal
3.0
11.5
59
228
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
5.0
11.2
25
54
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.5
10.8
39
121
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.8
10.7
19
17
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
10.7
76
347
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.6
10.2
19
19
J01EA01
ATC
trimethoprim; systemic
2.3
10.1
109
599
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
10.0
99
524
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
9.9
134
805
C03CA01
ATC
furosemide; systemic
2.2
9.9
167
1094
N03AX12
ATC
[U] gabapentin; oral
2.7
9.9
58
240
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
9.9
29
78
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.4
9.7
37
119
ZYC01, ,
SPAT
3.3
9.5
38
126
N05AX12
ATC
aripiprazole; systemic
12.9
9.5
16
13
Z74.3
ICD-10 Finland
Need for continuous supervision
+∞
9.4
9
*
WX892
NOMESCO Finland
Monitored bed care
3.4
9.4
35
111
A60
ICPC
General and Unspecified, Result test/procedure
4.2
9.2
25
63
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
9.2
37
123
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.9
9.1
48
187
UKC02
NOMESCO Finland
Cystoscopy
2.3
8.7
78
392
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
8.6
92
498
WYA20
NOMESCO Finland
Home visit
4.3
8.4
22
54
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
9.9
8.4
16
17
Z75.0
ICD-10 Finland
Medical services not available in home
+∞
8.4
8
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
8.4
65
307
WX882
NOMESCO Finland
High dependency care
6.8
8.3
20
31
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
8.2
59
268
N03AX14
ATC
levetiracetam; systemic
7.6
8.1
18
25
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.6
8.0
27
80
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.3
7.8
30
97
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
18.9
7.7
11
6
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
4.1
7.6
21
54
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
7.5
18
41
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
7.5
23
64
N06AB06
ATC
sertraline; oral
3.0
7.4
35
128
Z75.8
ICD-10 Finland
Other problems related to medical facilities and other health care
+∞
7.3
7
*
ZYB04, ,
SPAT
30.8
7.2
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
7.0
23
67
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
14.2
6.9
11
8
SPAT1193
SPAT
Pap smear
4.4
6.8
17
40
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.4
6.8
50
229
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
41.0
6.8
8
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3.9
6.8
20
54
S97
ICPC
Chronic ulcer skin
2.8
6.7
34
129
SPAT1252
SPAT
Overall medication plan or its review
2.9
6.7
32
118
WW200, ,
SPAT
2.0
6.6
83
472
G35
ICD-10 Finland
Multiple sclerosis
12.6
6.6
11
9
N06DX01
ATC
memantine; oral
2.3
6.6
56
273
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.5
6.6
42
180
R40.0
ICD-10 Finland
Somnolence
71.3
6.4
7
*
N05CD07
ATC
temazepam; oral
2.2
6.4
62
319
G20
ICD-10 Finland
Parkinson disease
3.7
6.3
20
57
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.6
6.3
17
32
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.5
6.2
15
24
R33
ICD-10 Finland
Retention of urine
2.4
6.2
46
211
N03AX09
ATC
lamotrigine; oral
6.0
6.2
16
28
ZYC01
NOMESCO Finland
Remote contact by phone
3.9
6.2
18
48
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.1
60
310
SPAT1216
SPAT
Assessment of functional ability
2.1
6.1
63
332
NFQ20
NOMESCO Finland
Amputation of femur
6.9
6.1
14
21
M03BX01
ATC
baclofen; systemic
6.3
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
89
255
4.51
29.01
6.5
8.1
122.06
119.70
g/l
0.55
89
246
74
185
4.95
28.57
6.4
5.9
25.54
24.26
mmol/l
1.82
74
173
131
548
3.43
24.02
9.7
5.0
1.02
1.02
kg/l
0.24
108
363
92
321
3.66
22.20
7.3
7.1
5.19
5.09
kpa
0.43
92
301
92
321
3.66
22.20
7.3
7.1
11.42
11.44
kpa
0.01
92
301
91
322
3.60
21.41
7.4
7.1
2.55
0.95
mmol/l
5.19
82
262
139
637
3.16
21.39
8.7
4.7
0.00
0.01
estimate
0.50
14
186
46
111
4.70
18.17
7.6
4.6
2.07
1.57
%
2.56
46
99
56
184
3.50
14.37
2.2
1.6
—
—
—
0
0
26
26
10.82
13.76
2.1
1.8
—
—
—
0
0
32
77
4.52
12.58
1.5
1.2
—
—
—
0
0
145
865
2.28
11.25
10.0
4.6
0.00
0.07
estimate
1.47
14
175
108
599
2.24
9.69
10.3
3.8
0.00
0.18
estimate
0.58
14
158
169
1139
2.08
8.96
9.4
4.4
0.00
1.50
estimate
0.50
18
200
95
519
2.20
8.71
2.1
1.8
410.78
27857580.06
pmol/l
0.50
90
420
166
1122
2.04
8.61
9.6
4.5
0.00
0.00
estimate
-0.00
17
213
166
1133
2.01
8.26
9.5
4.5
0.00
7.42
estimate
0.50
18
219
178
1317
1.84
6.27
10.4
5.4
7.25
6.84
mmol/l
1.46
178
1240
63
333
2.12
6.09
2.1
1.8
—
—
—
0
0
60
312
2.15
6.04
2.3
1.9
—
—
—
0
0
138
953
1.81
6.03
5.9
4.7
63.11
48.61
ng/l
0.30
118
737
194
1498
1.80
5.69
9.9
5.4
9122.80
2197.22
e6/l
—
5
46
31
133
2.48
4.85
1.5
1.5
—
—
—
0
0
73
439
1.87
4.83
2.4
1.9
—
—
—
0
0
83
522
1.81
4.75
2.0
1.8
1135.14
1114.28
nmol/l
0.11
71
389
22
83
2.78
4.43
12.3
3.0
25.77
24.89
mmol/l
0.40
22
83
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
6
11.90
4.29
1.0
1.0
—
—
—
0
0
7
6
11.90
4.29
1.0
1.0
—
—
—
0
0
153
1170
1.61
4.11
11.7
7.0
1.21
1.21
mmol/l
0.15
142
967
8
10
8.18
4.08
1.1
1.0
91.63
107.50
pmol/l
—
8
10
17
60
2.94
3.86
1.5
1.3
—
—
—
0
0
0
92
0.00
3.54
0.0
2.0
—
3.58
—
0
69
6
6
10.16
3.51
34.5
4.7
1.16
1.18
mmol/l
—
6
6
16
58
2.86
3.48
1.6
1.4
241.73
352.01
ug/g
1.31
11
33
137
1051
1.55
3.45
6.7
5.1
33.76
34.45
g/l
0.69
130
963
96
693
1.56
3.11
2.6
2.4
2.67
3.16
mg/l
1.06
91
592
73
506
1.58
2.79
5.4
4.0
64.53
304.97
ng/l
2.66
63
448
7
15
4.75
2.61
1.0
1.0
—
—
—
0
0
6
11
5.54
2.55
1.2
1.0
—
—
—
0
0
7
17
4.19
2.37
1.3
1.0
—
—
—
0
0
9
29
3.17
2.24
1.7
1.2
—
—
—
0
0
8
24
3.39
2.19
2.1
2.6
—
—
—
0
0
9
30
3.06
2.16
2.6
2.8
561.67
479.30
mg
—
9
30
7
19
3.74
2.16
1.3
1.0
—
—
—
0
0
6
15
4.06
2.05
1.3
1.1
—
—
—
0
0
6
15
4.06
2.05
2.3
3.9
2.67
0.73
%
—
6
15
11
45
2.50
1.95
1.6
1.6
18.11
25.09
iu/l
0.42
11
36
13
58
2.30
1.93
1.4
1.5
7.30
0.03
iu/ml
—
6
11
6
18
3.38
1.75
1.5
1.4
—
—
—
0
0
6
18
3.38
1.75
1.5
1.4
—
—
—
0
0
116
952
1.35
1.75
3.2
2.8
—
—
estimate
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
83
1.98
1.68
1.5
2.8
0.52
0.36
iu/ml
—
8
42
172
1928
0.75
1.64
5.5
5.9
2.38
2.51
mmol/l
1.23
164
1722
179
1576
1.33
1.64
46.2
23.3
14.34
13.95
%
3.12
179
1551
165
1858
0.76
1.61
4.9
5.1
1.32
1.43
mmol/l
2.87
156
1651
33
484
0.64
1.61
2.4
3.2
1.00
0.83
ug/l
0.38
27
321
17
92
1.90
1.59
4.6
2.9
—
—
—
0
0
121
1013
1.32
1.56
2.7
2.6
—
—
—
0
0
168
1874
0.77
1.44
5.0
5.2
4.16
4.39
mmol/l
2.09
158
1685
37
260
1.48
1.35
3.9
5.1
1.57
1.72
mmol/l
0.08
30
206
10
48
2.12
1.29
1.9
1.6
—
—
—
0
0
24
155
1.59
1.27
13.9
4.0
3.83
2.44
mmol/l
1.09
15
118
8
36
2.25
1.25
2.1
1.8
—
—
—
0
0
9
45
2.03
1.24
1.3
1.4
—
—
—
0
0
32
224
1.48
1.20
3.1
4.2
4.24
4.33
kpa
0.10
27
212
136
1189
1.26
1.19
14.8
9.0
5.19
4.45
e9/l
1.68
123
1033
161
1780
0.80
1.15
4.5
4.4
1.38
1.25
mmol/l
1.43
153
1566
10
51
1.99
1.12
1.9
1.5
—
—
—
0
0
173
1892
0.80
1.09
5.1
5.4
6.28
6.08
mmol/l
0.85
165
1666
7
32
2.21
1.08
2.0
1.8
—
—
—
0
0
31
223
1.43
1.03
8.5
8.6
1.46
1.39
mmol/l
0.14
31
218
9
51
1.79
0.95
1.6
1.4
—
—
—
0
0
9
51
1.79
0.95
1.6
1.4
—
—
—
0
0
41
518
0.76
0.87
2.4
2.4
—
—
—
0
0
6
30
2.02
0.87
11.0
3.5
10.00
12.58
pmol/l
—
6
30
215
2018
1.22
0.84
37.2
18.5
32.69
28.90
mg/l
0.92
207
1699
50
404
1.28
0.83
3.6
2.6
2.43
2.22
g/l
1.31
50
364
8
47
1.72
0.81
1.7
2.0
—
—
—
0
0
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
11
67
1.67
0.76
1.9
1.4
—
—
—
0
0
7
42
1.68
0.69
1.7
1.6
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
24
184
1.33
0.60
1.5
1.4
—
—
—
0
0
18
132
1.39
0.58
4.1
3.6
53.55
47.54
%
0.48
18
125
63
550
1.18
0.53
2.7
3.0
351.74
362.37
umol/l
0.28
58
467
79
703
1.17
0.53
2.0
1.8
20.07
20.23
nmol/l
0.03
73
570
6
100
0.59
0.52
11.5
4.4
25.17
25.66
mmol/l
—
6
93
9
64
1.42
0.52
1.3
1.2
—
—
—
0
0
9
64
1.42
0.52
1.3
1.2
—
—
—
0
0
6
40
1.51
0.52
1.2
2.0
—
—
—
0
0
7
108
0.64
0.49
2.0
2.1
—
—
—
0
0
7
45
1.57
0.49
6.1
2.7
15.43
15.49
%
—
7
45
5
31
1.62
0.43
4.0
3.0
17.40
40.87
u/ml
—
5
31
5
32
1.57
0.42
1.8
1.7
—
—
—
0
0
8
59
1.37
0.41
3.6
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
193
1851
1.11
0.38
35.5
18.2
69.21
72.49
ml/min/173m2
0.82
160
1715
10
72
1.40
0.37
5.4
4.6
2.07
1.78
mg/l
—
10
56
6
41
1.47
0.36
1.5
1.8
—
—
—
0
0
6
42
1.44
0.35
1.0
1.1
22.88
35.42
u/l
—
6
36
20
163
1.24
0.35
11.3
9.3
25.68
24.48
mmol/l
1.00
20
155
32
276
1.18
0.33
2.7
4.1
5.05
47.18
ug/l
0.90
24
240
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
7
97
0.72
0.31
1.6
2.0
—
—
—
0
0
61
667
0.89
0.30
6.5
3.5
0.69
0.44
e6/l
0.51
50
515
12
93
1.30
0.30
1.4
1.2
149.98
125.85
u/ml
—
6
39
21
176
1.21
0.29
4.7
3.8
43.75
55.76
ml/min/173m2
—
8
83
14
113
1.25
0.27
3.9
3.3
25.64
24.57
mmol/l
0.71
14
106
8
66
1.22
0.27
1.4
1.7
—
—
—
0
0
13
160
0.80
0.26
18.1
4.1
1.17
1.22
mmol/l
1.31
13
136
110
1047
1.08
0.23
2.2
2.3
87.60
91.59
pmol/l
0.52
73
552
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
174.57
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
13.89
—
0
12
0
13
0.00
0.21
0.0
4.8
—
218.00
—
0
13
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
155
1501
1.07
0.20
4.7
3.8
14.90
15.16
pmol/l
0.62
146
1301
44
405
1.10
0.20
1.5
1.2
3.87
2.08
u/ml
—
9
95
12
100
1.21
0.18
1.1
1.3
—
38.79
—
0
9
7
61
1.15
0.17
3.9
1.7
—
—
—
0
0
71
673
1.07
0.17
4.9
5.2
22.17
22.12
%
0.01
38
350
13
111
1.18
0.16
2.1
2.6
—
11.93
—
0
7
158
1540
1.05
0.15
5.4
4.1
18.98
14.77
mm/h
1.84
152
1389
9
82
1.10
0.15
1.0
1.0
—
—
—
0
0
7
88
0.79
0.14
3.6
1.7
—
—
—
0
0
8
97
0.82
0.14
3.6
1.8
—
—
—
0
0
125
1215
1.05
0.13
3.8
3.3
56.97
55.41
u/l
0.07
117
1118
25
272
0.91
0.12
1.6
1.2
0.97
9.53
u/ml
—
6
81
5
45
1.11
0.10
1.0
1.3
968.00
334.50
pmol/l
—
5
45
5
48
1.04
0.09
2.4
1.2
—
2.33
—
0
8
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
46
479
0.95
0.08
1.5
1.8
1.29
1.55
mg/l
0.45
35
388
180
1823
0.97
0.07
6.0
4.9
2.02
2.04
mu/l
0.07
171
1598
9
88
1.02
0.07
1.3
1.3
—
—
—
0
0
28
293
0.95
0.05
12.2
9.3
—
—
—
0
0
40
413
0.96
0.04
5.3
3.1
1.00
1.30
e6/l
0.49
21
243
32
309
1.04
0.04
1.3
1.3
11.40
37.60
iu/ml
3.43
13
97
24
249
0.96
0.02
6.8
3.7
—
—
—
0
0
15
157
0.95
0.01
3.2
1.7
—
—
—
0
0
17
177
0.96
0.01
1.7
1.4
—
—
—
0
0
73
737
0.99
0.01
3.8
3.9
19.68
9.84
mg/mmol
1.01
45
468
11
104
1.06
0.01
1.5
1.3
241.73
179.40
u/ml
0.14
11
94
36
362
0.99
0.00
5.8
3.2
1.18
1.72
e6/l
0.33
18
195
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
86.00
—
0
9
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
13.34
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
96.38
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
25
250
1.00
-0.00
1.3
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.6
—
5.90
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
1.34
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROBL_RELATED_CARE__DEPENDENCY – Problems related to care-provider dependency
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).